VERU INC. (VERU): Nasdaq/NYSE listing notice — Veru receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period through July 23, 2024
VERU INC.
Nasdaq notified Veru on Jan 25, 2024 that its closing bid price was below $1.00 for 30 consecutive business days.
Company has until July 23, 2024 to regain compliance by closing at $1.00 or more for 10 consecutive trading days.
Failure to cure may qualify for an additional 180-day period if other listing standards are met and a reverse stock split is considered.
No immediate impact on trading; stock continues on Nasdaq Capital Market during the cure period.
VERU INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
January 25, 2024, Veru Inc. (the “Company”) received notification from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company’s common stock (the “Common Stock”) was below $1.00 per share for 30 consecutive business days. The notification does not impact the listing of the Company’s Common Stock on the Nasdaq Capital Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.